Expert Review Of Vaccines

Expert Review Of Vaccines

疫苗专家评审

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Expert Review Of Vaccines》是由Taylor and Francis Ltd.出版社于2002年创办的英文国际期刊(ISSN: 1476-0584,E-ISSN: 1744-8395),该期刊长期致力于免疫学领域的创新研究,主要研究方向为医学-免疫学。作为SCI、SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA未开放获取模式(OA占比0.1715...%),以发表免疫学领域等方向的原创性研究为核心(研究类文章占比73.20%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在97篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Expert Review Of Vaccines审稿周期约为偏慢,4-8周。该刊近年未被列入国际预警名单,年发文量约97篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 97 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
IMMUNOLOGY 免疫学
3区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
IMMUNOLOGY 免疫学
3区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
3区
IMMUNOLOGY 免疫学
3区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
IMMUNOLOGY 免疫学
3区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
2区
IMMUNOLOGY 免疫学
2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q1 42 / 183

77.3

学科:IMMUNOLOGY SCIE Q2 75 / 183

59.29

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q2 49 / 183

73.5

学科:IMMUNOLOGY SCIE Q2 70 / 183

62.02

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q1 39 / 181

78.7

学科:IMMUNOLOGY SCIE Q2 66 / 181

63.81

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:9.9 SJR:1.28 SNIP:1.301
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology Q1 39 / 328

88%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Immunology Q1 42 / 243

82%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Drug Discovery Q1 28 / 161

82%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Molecular Medicine Q1 35 / 179

80%

期刊发文

  • Epidemiological shifts in coxsackievirus A-induced hand, foot, and mouth disease in China, 2008-202

    Author: Yu, Li; Zhao, Heng; Zhao, Xin; Wang, Jingjing; Liao, Yun; Li, Jun; Zheng, Huiwen; Li, Dandan; Li, Heng; Shi, Haijing; Liu, Longding

    Journal: EXPERT REVIEW OF VACCINES. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1080/14760584.2026.2652927

  • Evaluation of varicella outbreak control following implementation of a two-dose free vaccination policy in Wuxi, China (2014-2024

    Author: Yang, Min; Wang, Lingling; Wang, Xuwen; Zhou, Lu; Yang, Xu; Jiang, Jingfeng; Yang, Kun; Chen, Qiujin; Xiu, Shixin; Lu, Yihan

    Journal: EXPERT REVIEW OF VACCINES. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1080/14760584.2026.2653758

  • An active surveillance study of adverse events following to Japanese encephalitis inactivated vaccine (JE-I) in Jiangsu Province, China, 2024-202

    Author: Liu, Li; Zhang, Lei; Hu, Ran; Kang, Guodong; Yu, Jing; Sun, Xiang; Wang, Zhiguo

    Journal: EXPERT REVIEW OF VACCINES. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1080/14760584.2026.2653748

  • Vaccine hesitancy among 0-6-year-olds' guardians in Chongqing: a cross-sectional survey revealing how immunization program managers' robust comprehensive capacity for adverse events following immunization (AEFI) management mitigates hesitanc

    Author: Xu, Binyue; Wang, Qing; Xu, Jiawei; Li, Jianqiao; Bai, Ningpei; Zhou, Chunbei

    Journal: EXPERT REVIEW OF VACCINES. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1080/14760584.2026.2640140

  • Influenza vaccination willingness and influencing factors among older adults in Chongqing China: a cross-sectional study based on the WHO's behavioral and social drivers of vaccination framewor

    Author: Yang, Jule; Yang, Shuang; Xiong, Yu; Li, Baisong; Fu, Xiaoqing; Jia, Mengmeng; Qi, Li

    Journal: EXPERT REVIEW OF VACCINES. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1080/14760584.2026.2638826

  • Fc-mediated immune effector functions elicited by recombinant and live-attenuated herpes zoster vaccine

    Author: Huang, Zhuangzhuang; Jin, Pengfei; Pan, Hongxing; Wei, Mingwei; Liang, Qi; Gan, Mingzhi; Li, Simin; Zhai, Xiangjun; Li, Jingxin

    Journal: EXPERT REVIEW OF VACCINES. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1080/14760584.2026.2626919

  • A self-controlled case series study on the safety of a live attenuated herpes zoster vaccine in Chin

    Author: Cao, Xiang; Wei, Mingwei; Huo, Xiang; Liu, Yuanbao; Xu, Ming; Wang, Xiaoshan; Huang, Xianzhang; Ma, Hui; Xu, Na; Lu, Qiang; Ma, Shihua; Jin, Pengfei; Li, Jingxin

    Journal: EXPERT REVIEW OF VACCINES. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1080/14760584.2026.2626926

  • Adherence and efficacy of the 0-7-21-day versus the 0-1-6-month hepatitis B vaccination schedules among people who use drugs: a two-year randomized controlled tria

    Author: Hou, Xianbin; Li, Ning; Zhang, Hailan; Liu, Wenjun; Zheng, Haichao; Zhuang, Tianyi; Zou, Zhuoru; Xia, Ruyi; Liu, Ying; Zhang, Hongyan; Hou, Tiejun; Chen, Zhijun; Chen, Baozhong; Wang, Fuzhen; Wang, Lirong; Wei, Xiaoli; Zhuang, Guihua

    Journal: EXPERT REVIEW OF VACCINES. 2026; Vol. 25, Issue 1, pp. -. DOI: 10.1080/14760584.2026.2626920